Free Trial
OTCMKTS:AMAR

Amarillo Biosciences (AMAR) Stock Price, News & Analysis

Amarillo Biosciences logo

About Amarillo Biosciences Stock (OTCMKTS:AMAR)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
6,100 shs
Average Volume
18,253 shs
Market Capitalization
$25.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Amarillo Biosciences is a biotechnology company focused on developing low-dose oral interferon alpha therapies. Its work has centered on an oral formulation intended to influence immune responses and potentially treat viral and other immune-related conditions.

The company has investigated the approach for a range of conditions, including hepatitis and other viral infections, as well as dry eye disease. These therapies have been described as developmental rather than established, commercially available products.

AI Generated. May Contain Errors.

Receive AMAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amarillo Biosciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AMAR Stock News Headlines

Amarillo native earns Rising Star award
RIP USD
In 1974, a quiet deal between Henry Kissinger and the Saudis reshaped America's monetary order overnight, with no announcement and no vote in Congress. Decades later, the dollar had lost more than 84% of its purchasing power even as millionaire ranks surged into the millions. Financial reporter Kimi Weintraub sits down to explore a new, largely unnoticed shift in America's monetary system, one tied to executive orders and a reported 13-nation agreement.tc pixel
Gufic Biosciences Ltd (GUFI)
Best Internet Providers In Amarillo, Texas Of 2023
See More Headlines

AMAR Stock Analysis - Frequently Asked Questions

Amarillo Biosciences, Inc. (OTCMKTS:AMAR) released its quarterly earnings data on Wednesday, November, 14th. The company reported ($0.01) EPS for the quarter. The company had revenue of $20 thousand for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Amarillo Biosciences investors own include Cerecor (CERC), Etsy (ETSY), Ampliphi Biosciences (APHB), Aurora Cannabis (ACBFF), AbbVie (ABBV), AMC Entertainment (AMC) and Aurora Cannabis (ACB).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Technology Hardware, Storage & Peripherals
Sub-Industry
Technology Hardware, Storage & Peripherals
Current Symbol
OTCMKTS:AMAR
CIK
1014763
Fax
N/A
Employees
2
Year Founded
1984

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.45 million
Net Margins
-41,453.98%
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-574.29%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.03
Quick Ratio
0.07

Sales & Book Value

Annual Sales
$20 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.03) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
42,066,000
Free Float
N/A
Market Cap
$25.24 million
Optionable
Not Optionable
Beta
-0.06

Social Links

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (OTCMKTS:AMAR) was last updated on 5/21/2021 by MarketBeat.com Staff.
From Our Partners